Vaccines, blood, antisera, toxins and cultures in Brazil | The Observatory of Economic Complexity

About

Exports In 2022, Brazil exported $310M in Vaccines, blood, antisera, toxins and cultures, making it the 30th largest exporter of Vaccines, blood, antisera, toxins and cultures in the world. At the same year, Vaccines, blood, antisera, toxins and cultures was the 102nd most exported product in Brazil. The main destination of Vaccines, blood, antisera, toxins and cultures exports from Brazil are: China ($151M), Uruguay ($21.4M), United Kingdom ($19.9M), Germany ($9.72M), and Paraguay ($7.9M).

The fastest growing export markets for Vaccines, blood, antisera, toxins and cultures of Brazil between 2021 and 2022 were China ($149M), Uruguay ($14.7M), and Japan ($7.62M).

Imports In 2022, Brazil imported $4.71B in Vaccines, blood, antisera, toxins and cultures, becoming the 16th largest importer of Vaccines, blood, antisera, toxins and cultures in the world. At the same year, Vaccines, blood, antisera, toxins and cultures was the 12th most imported product in Brazil. Brazil imports Vaccines, blood, antisera, toxins and cultures primarily from: Belgium ($1.11B), Switzerland ($717M), United States ($702M), Germany ($526M), and Ireland ($336M).

The fastest growing import markets in Vaccines, blood, antisera, toxins and cultures for Brazil between 2021 and 2022 were Germany ($344M), Belgium ($318M), and Argentina ($150M).

COMPANIES In 2023, leading companies such as Dole Fresh Fruit (1) were at the forefront of shipping Vaccines, blood, antisera, toxins and cultures from Brazil to the United States.

Latest Trends

September 2024

About

Overview In September 2024 Brazil's Vaccines, blood, antisera, toxins and cultures exports accounted up to $10.3M and imports accounted up to $424M, resulting in a negative trade balance of $413M. Between September 2023 and September 2024 the exports of Brazil's Vaccines, blood, antisera, toxins and cultures have increased by $1.21M (13.4%) from $9.08M to $10.3M, while imports increased by $96.9M (29.7%) from $327M to $424M.

Destinations In September 2024, Vaccines, blood, antisera, toxins and cultures were exported mostly to Colombia ($1.62M), United States ($1.24M), Paraguay ($794k), Indonesia ($737k), and Uruguay ($687k), and were imported mostly from Puerto Rico ($70.7M), Switzerland ($51M), United States ($46.6M), Ireland ($45.6M), and France ($44.7M).

Growth In September 2024, the increase in Vaccines, blood, antisera, toxins and cultures's year-by-year exports was explained primarily by an increase in exports to Uruguay ($1.93M or 16.6k%), United Kingdom ($1.25M or 51.4%), and Angola ($368k or 110%). In September 2024, the increase in Vaccines, blood, antisera, toxins and cultures's year-by-year imports was explained primarily by an increase in imports from Belgium ($241M or 243%), Germany ($42M or 104%), and Austria ($25M or 1.18k%).

Subnational Monthly Trade

Time Scale

Year

Quarter

Month

Flow

Exports

Imports

Color

Trade Value

Growth

Growth (%)

EXPORT GROWTH (September 2023 - September 2024)$1.21M(13.4%)

IMPORT GROWTH (September 2023 - September 2024)$96.9M(29.7%)

MAIN EXPORTER (September 2024)São Paulo$10.4M

MAIN DESTINATION (September 2024)Colombia$1.62M

This section shows Vaccines, blood, antisera, toxins and cultures's exports and imports data at subnational level for Brazil. Click any date in the line plot, any subnational region in the geomap, or any destination or origin country to explore the exports or imports behavior of Vaccines, blood, antisera, toxins and cultures over time.

For full datasets download visit Bulk Download page.

Go to Bulk Download